Lipikind 10 Tablet contains Atorvastatin 10mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia, effectively reducing elevated levels of low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin exerts its therapeutic effect by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing hepatic cholesterol production and upregulating LDL receptors to enhance clearance of circulating LDL particles. Lipikind 10 is prescribed as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with atherosclerotic cardiovascular disease or those at high risk. The recommended dosage should be individualized based on patient response and lipid profile, with regular monitoring of liver function tests and lipid levels advised during therapy. Common adverse effects include headache, myalgia, and gastrointestinal disturbances; rare but serious effects include hepatotoxicity and rhabdomyolysis. Caution is warranted in patients with hepatic impairment or concomitant use of interacting drugs.